Kaleido Biosciences, Inc.·4

Sep 2, 4:20 PM ET

Korn Jerald 4

4 · Kaleido Biosciences, Inc. · Filed Sep 2, 2021

Insider Transaction Report

Form 4
Period: 2021-09-01
Korn Jerald
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-01+100,000100,000 total
    Exercise: $6.29Exp: 2031-08-31Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION